This situation together with the ever-growing knowledge regarding the role played by the enzyme in infectious diseases, pave the way for considering HO-1 and the products of its activity as important targets for the development of new therapies for infectious diseases and in particular for those involving pathogens that have proved difficult to treat with conventional antibiotics or readily develop resistance to the same agents. This evidence concerns the gene HMOX1 and infectious disease.